PharmaSphere Consulting ApS Financials, key figures and credit report
Gross profit 2 479.8 kDKK FY 2025 -2.5% vs 2024
EBIT 412.0 kDKK FY 2025 -53.6% vs 2024
Net debt - 381.0 kDKK FY 2025 -25.9% vs 2024
Quick ratio 2.1 FY 2025 -0.1 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 137.83 | 916.03 | 1 680.38 | 2 544.33 | 2 479.82 |
| Employee benefit expenses | -21.43 | - 570.61 | -1 267.09 | -1 656.82 | -2 067.80 |
| EBIT | 116.40 | 345.42 | 413.29 | 887.51 | 412.02 |
| Other financial income | 0.07 | 1.88 | 5.12 | ||
| Other financial expenses | -4.01 | -3.58 | -2.95 | -6.04 | -4.60 |
| Pre-tax profit | 112.39 | 341.84 | 410.41 | 883.35 | 412.53 |
| Income taxes | -24.73 | -75.44 | -90.77 | - 194.85 | -90.91 |
| Net earnings | 87.67 | 266.40 | 319.63 | 688.49 | 321.62 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 70.40 | 687.69 | 835.41 | 467.48 | |
| Current amounts owed by group member comp. | 175.75 | ||||
| Prepayments and accrued income | 16.30 | ||||
| Current other receivables | 1.39 | 29.34 | 21.75 | 64.22 | 1.88 |
| Short term receivables total | 1.39 | 99.74 | 709.44 | 1 075.38 | 485.66 |
| Cash and bank deposits | 203.06 | 563.29 | 303.35 | 303.08 | 395.69 |
| Cash and cash equivalents | 203.06 | 563.29 | 303.35 | 303.08 | 395.69 |
| Balance sheet total (assets) | 204.45 | 663.03 | 1 012.78 | 1 378.46 | 881.35 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 87.50 | 250.00 | 330.00 | 600.00 | |
| Retained earnings | -87.23 | - 249.56 | - 313.16 | - 593.53 | 94.96 |
| Profit of the financial year | 87.67 | 266.40 | 319.63 | 688.49 | 321.62 |
| Shareholders equity total | 137.94 | 316.84 | 386.47 | 744.96 | 466.58 |
| Non-current liabilities total | |||||
| Current trade creditors | 12.00 | 17.50 | 71.75 | 16.00 | 22.00 |
| Current owed to participating | 0.41 | 0.42 | |||
| Current owed to group member | 11.23 | 75.44 | 14.32 | ||
| Short-term deferred tax liabilities | 24.73 | 75.44 | 90.77 | 194.85 | 90.91 |
| Other non-interest bearing current liabilities | 18.56 | 253.25 | 388.35 | 422.24 | 287.12 |
| Current liabilities total | 66.51 | 346.19 | 626.31 | 633.50 | 414.77 |
| Balance sheet total (liabilities) | 204.45 | 663.03 | 1 012.78 | 1 378.46 | 881.35 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated